Using Methotrexate in #PMR Where in other inflammatory rheumatic disorders, such as RA and PsA, early initiation of MTX is common practice, this is not the case in PMR. Treatment of PMR is still largely based on GC. https://t.co/pQtmYvF2NS https://t.co/wJTpFPqmlw

#PMR and Palindromic Rheumatism Similarities https://t.co/uJ4hJSA0hL https://t.co/rFINkKZh7l

Check out the latest therapeutic update for axSpA in this video series dedicated to creating a better understanding of treatment goals.https://t.co/VTQI0SzHpO https://t.co/H3yBcnUvwu

2023 EULAR Lupus Management Recommendations EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations. https://t.co/Fzh8F33u3U https://t.co/2baAVsm8Bo

IL-2 receptor (sCD25) levels as a biomarker of RA-ILD? Study of 294 RA pts (56 w/ ILD) & 58 healthy controls (HCs) (ILD confirmed by HRCT). sCD25 sensitivity 51% & specificity 77%,; it elevated in RA-ILD subtypes (UIP, NSIP); but didnt correlate w/ HRCT https://t.co/1gJ635tu8a https://t.co/aYamfJwJi2

JAKne? Systematic review &meta-analysis (25 studies, 10 839 pts), JAK inhibitor use was associated with an elevated odds of acne (OR 3-5 for UPA, TOFA, BARI, Deucra; but higher for abrocitinib (OR 13.5). Seen in Derm pts but hardly at all in Rheum pts https://t.co/XdHmARnxpu https://t.co/N7Bm5GIgjd

Looks like #PMR - But is it? Patients referred to rheumatologists for suspected PMR - but is it? And what's the role of imaging to help make the diagnosis? https://t.co/oinfFXE978 https://t.co/4aAHrYbjZD

Could Methotrexate Work in Hand Osteoarthritis? Lancet reports the results of the METHODS study from Australia where hand osteoarthritis (HOA) patients benefitted from 6 months of methotrexate (MTX) - as long as there was MRI synovitis! https://t.co/GhVB7WzJLQ https://t.co/Lt0pvm3RCW

12.3 million Americans over 50 have osteoporosis; 47 million have osteopenia. W/ OP Fx the risk of repeat Fx is highest in 1st 6 mos, yet 8% of Medicare pts w/ Fx have a diagnostic bone density scan (less in African Americans 5%) https://t.co/2mogEEk3tq https://t.co/9tjwXg0WzZ https://t.co/ruLnjm4kXr

Tuesday Nite Rheumatology webinar on the use of steroid-sparing drugs in patients with #PMR. Featuring Panelists: Drs. David Liew, Robert Spiera, Sarah Mackie, Anisha Dua Moderator: Dr. Sebastian Sattui https://t.co/HDXCG1bq2m https://t.co/95vfTnXtNP

Tocilizumab Use in #GCA. In 10 yrs, 114 GCA pts started on TCZ after mean 4.5 mos & Rx for 2.3 yrs. GCA Relapse rates: - before TCZ 0.84/PY - on TCZ 0.28/PY (P<0.001) - post TCZ D/C 0.64/PY 52 pts D/C TCZ after 16.8 mos & 27 (52%) relapsed after 8.4 mo https://t.co/D3INiMdC4U https://t.co/aD2rijR6xd